T-Prolymphozyten Leukämie

Hopfinger G in: Hallek M, Emmerich B (Hrsg). Bremen, London, Boston: UniMed Verlag; 2005. (ISBN 3895998656)

Comparison of BEACOPP and ABVD chemotherapy in intermediate stage Hodgkin’s lymphoma: Results of the fourth interim analysis of the HD 11 trial of the GHSG_x000D_

Klimm, BC; Engert, A; Brillant, C; Eich, HT; Mueller-Hermelink, HK; Herrmann, R; Ho, A; Hiddemann, W; Greil, R; Diehl, V; ASCO Annual Meeting Proceedings, 16_suppl_x000D_ _x000D_ . 2005. 23: 6507-6507.

Thalidomide-dexamethasone versus melphalan-prednisolone as first line treatment in elderly patients with multiple myeloma: An interim analysis_x000D_

Ludwig, H; Drach, J; Tothova, E; Gisslinger, H; Jaksic, B; Linkesch, W; Hajek, R; Greil, R; Fridrik, M; Labar, B; Zojer, N ASCO Annual Meeting Proceedings, 16_suppl_x000D_ _x000D_ . 2005. 23: 6537-6537.

HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG)_x000D_

Diehl, V; Brillant, C; Engert, A; Mueller, RP; Mueller-Hermelink, HK; Hermann, R; Doerken, B; Kanz, L; Greil, R; Pfistner, B; ASCO Annual Meeting Proceedings_x000D_ . 2005.

The benefits of sequencing adjuvant tamoxifen and anastrozole in postmenopausal women with hormone-responsive early breast cancer: 5 year-analysis of ABCSG Trial 8_x000D_

Jakesz, R; Gnant, M; Greil, R; Tausch, C; Samonigg, H; Kwasny, W; Kubista, E; Stierer, M; Luschin, G; Mittlboeck, M; Breast Cancer Research and Treatment, 2005, Band 94, S10-S10_x000D_ . 2005.

Extended adjuvant treatment with anastrozole: Results from the Austrian Breast and Colorectal Cancer Study Group Trial 6a (ABCSG-6a)

Jakesz, R; Samonigg, H; Greil, R; Gnant, M; Schmid, M; Kwasny, W; Kubista, E; Mlineritsch, B; Tausch, C; Stierer, M; on behalf of the ABCSG _x000D_ Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings._x000D_ Vol 23, No 16S (June 1 Supplement), 2005: 527. 2005.

Long-term results of autologous stem cell transplantation for Hodgkin“s disease (HD) and low-/intermediate-grade B non-Hodgkin“s lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).

Nachbaur, D; Greinix, HT; Koller, E; Krieger, O; Linkesch, W; Kasparu, H; Pober, M; Hinterberger, W; Hausmaninger, H; Heistinger, M; Ulsperger, E; Karlhuber, S; Schwinger, W; Lindner, B; Ann Hematol. 2005; 84(7): 462-473.

Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial.

Schmid, P; Schippinger, W; Nitsch, T; Huebner, G; Heilmann, V; Schultze, W; Hausmaninger, H; Wischnewsky, M; Possinger, K; J Clin Oncol. 2005; 23(3): 432-440.

1,10-epoxyhypocretenolides from the Azorean Endemic Leontodon rigens (Asteraceae)

Zidorn, C; Ellmerer, EP; Konwalinka, G; Ongania, KH; Schwaha, R; Greil, R; Joehrer, K; Perry, NB; Stuppner, H LETT ORG CHEM. 2005; 2(5): 461-464.

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of multiple myeloma.

Harrouseau, JL; Greil, R; Kloke, O; Ann Oncol. 2005; 16 Suppl 1:i45-i47